Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis

Authors

  • Amirreza Azimi MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Leila Ghelichi Department of Speech and Language Pathology, Rehabilitation Research Center, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
  • Maryam Tarameshlu Department of Speech Therapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.
  • Noureddinn Nakhostin Ansari Department of Physiotherapy, School of Rehabilitation, Sports Medicine Research Center, Tehran University of Medical Sciences, & Neuromusculoskeletal Research Center, Iran University of Medical Sciences. Tehran, Iran.
Abstract:

    Background: Dysphagia is frequently observed in patients with multiple sclerosis (MS). Dysphagia and its complications are common causes of morbidity and mortality in final stages of MS disease. This study aimed at determining the prevalence of dysphagia in Iranian patients with MS and identifying predictors associated with dysphagia.    Methods: A total of 230 MS patients were enrolled in this cross-sectional study.  Dysphagia was evaluated using Mann Assessment of Swallowing Ability (MASA). Demographic characteristics (age and gender), duration of the disease, disease course, and Expanded Disability Status Scale (EDSS) were recorded for all participants.      Results: In total, dysphagia was found in 85 participants (37%) with mild to severe dysphagia (mild 50.6%; moderate 29.4%; and severe 20%). The logistic regression model demonstrated that disability status in EDSS (OR= 2.1; 95% CI 0.5-1.2) and disease duration (OR= 2.3; 95% CI 0.4-1.1) predicts a high risk for dysphagia in MS patients.    Conclusion: Dysphagia is prevalent in Iranian patients with MS. Disability level and disease duration are significant predictors of dysphagia after MS.   

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effects of sensory and oral- motor exercises on oropharyngeal dysphagia in patients with multiple sclerosis

Introduction: Swallowing disorders are commonly observed in more than one-third of patients with multiple sclerosis. Dysphagia in these patients, decreases quality of life and increases a risk of dehydration and aspiration pneumonia. These complications are a common cause of death and morbidity in late multiple sclerosis. The aim of this research was to examine the effects of thermal-tactile s...

full text

Prevalence of Headache in Patients with Multiple Sclerosis

Background and purpose: Multiple Sclerosis (MS) is a common neurological disease in young adults. This study was performed to determine the prevalence of headache in these patients. Materials and methods: This descriptive-analytic study was carried out using convenient sampling in patients attending neurology clinics affiliated to Mazandaran University of Medical Sciences, 2017. Data analysis ...

full text

Seizure in Iranian patients with multiple sclerosis

BACKGROUND There is a broad variation in reported frequencies of seizure in multiple sclerosis (MS). In this study, the seizure and its characteristics analyzed among a large group of patients with MS. PATIENTS AND METHODS We reviewed the medical records of all definite MS patients referred to the MS Clinic of Kashani hospital, Isfahan, Iran, between 2007 and 2011. RESULTS Altogether, 34 ca...

full text

Molecular Analysis of rs2070744 and rs1799983 Polymorphisms of NOS3 Gene in Iranian Patients With Multiple Sclerosis

Introduction: Multiple Sclerosis (MS) is a disease of central nervous system that mainly causes lesions or plaques in the spinal cord and brain. The purpose of this study was to analyze the relation between c.-813C>T (rs2070744) and c.894G>T (rs1799983) polymorphisms of NOS3 gene and MS in Iranian patients. Methods: A total of 78 patients with MS and 80 healthy controls were screened for NOS3 ...

full text

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional interferon therapy were assigned to receive fingolimod 0.5 mg per day for 12 months. The number of D...

full text

Prevalence of Tremors in Patients With Multiple Sclerosis: A Cross-Sectional Study in Isfahan, Iran

Background: Multiple Sclerosis (MS) is a demyelinating disorder of the central nervous system. Tremors are a common problem in the patients suffering from MS which is mostly observed in the arms but can also affect the other body parts. There have been few studies on tremors among the MS patients.  Objectives: This study is the first to report the prevalence of tremor in a group of MS pat...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 31  issue 1

pages  882- 885

publication date 2017-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023